Sanofi attended the Invest Day on November 26, 2024
Upcoming Events
5Dec
2024
Deutsche Bank C-Suite Management Call Series
15:00 - 16:00 CET (Paris)
Broker Conference
13Dec
2024
Leerink Partners POLARxPRESS
13:45 - 14:45 EDT (Boston)
Broker Conference
30Jan
2025
Fourth Quarter & Full Year 2024 Results
Fourth quarter and full year 2024 results will be reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation will be followed by a Q&A session.
14:30 - 16:00 CET (8:30am – 10am EST)
Quarterly Results
Press Releases
December 6, 2024
Press Release: Availability of the profit and loss information of Sanofi excluding Opella
November 15, 2024
Communiqué de presse - Sanofi renforce la bioproduction d’anticorps en France avec un investissement de plus de 40 millions d’euros sur son site de Lyon Gerland
November 15, 2024
Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Subscribe to investor email alerts
Sign up to receive email alerts for various types of investor content
Contact Our Investor Relations Team
To join the Sanofi front desk,
Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00
To contact the Investor Relations team:
46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com